Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical updates on phase III trial of AM-101 in tinnitus

Jan. 16, 2015

FDA approves ear drop formulation of finafloxacin for acute otitis externa

Dec. 18, 2014

Salvat reports topline phase III results for combination otic solution in AOMT

Oct. 3, 2014

Phase Ib data of synthetic cis-retinoid therapy for patients with genetic retinal defects

Sep. 19, 2014

NicOx obtains antiviral eye drop program from Marinomed

Sep. 17, 2014

Otonomy releases phase III data for AuriPro in middle ear effusion

July 10, 2014

Autifony Therapeutics awarded grant to support phase IIa study of AUT-00063 for tinnitus

June 10, 2014

Close-field electroporation gene delivery for damaged cochlear hair cells regeneration

May 29, 2014

Novartis plans phase I/II study of CGF-166

May 15, 2014

Oricula Therapeutics receives NIH grant to further develop medicine to preserve hearing

May 2, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...